USA Molecular Diagnostics in Infectious Disease Testing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Molecular Diagnostics in Infectious Disease Testing market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Molecular Diagnostics in Infectious Disease Testing market. Detailed analysis of key players, along with key growth strategies adopted by Molecular Diagnostics in Infectious Disease Testing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Thermo Fisher Scientific

    • BioTheranostics

    • Roche

    • GenMark Diagnostics

    • Siemens

    • Qiagen

    • Luminex

    • Veridex

    • BioMerieux

    • Abbott

    • Genomix Biotech

    • BD

    By Type:

    • Polymerase Chain Reaction (PCR)

    • Isothermal Nucleic Acid Amplification Technology (INAAT)

    • Microarrays

    • Next-Generation Sequencing (NGS)

    • Hybridization

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Academic Institutes

    • Laboratories

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Molecular Diagnostics in Infectious Disease Testing Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2016 to 2027

      • 1.3.2 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) from 2016 to 2027

      • 1.3.3 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Microarrays from 2016 to 2027

      • 1.3.4 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Next-Generation Sequencing (NGS) from 2016 to 2027

      • 1.3.5 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Hybridization from 2016 to 2027

      • 1.3.6 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Clinics from 2016 to 2027

      • 1.4.3 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Academic Institutes from 2016 to 2027

      • 1.4.4 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Laboratories from 2016 to 2027

      • 1.4.5 USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Molecular Diagnostics in Infectious Disease Testing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Molecular Diagnostics in Infectious Disease Testing by Major Types

      • 3.4.1 Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

      • 3.4.2 Market Size and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT)

      • 3.4.3 Market Size and Growth Rate of Microarrays

      • 3.4.4 Market Size and Growth Rate of Next-Generation Sequencing (NGS)

      • 3.4.5 Market Size and Growth Rate of Hybridization

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Molecular Diagnostics in Infectious Disease Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Molecular Diagnostics in Infectious Disease Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Molecular Diagnostics in Infectious Disease Testing in Hospitals

      • 4.4.2 Market Size and Growth Rate of Molecular Diagnostics in Infectious Disease Testing in Clinics

      • 4.4.3 Market Size and Growth Rate of Molecular Diagnostics in Infectious Disease Testing in Academic Institutes

      • 4.4.4 Market Size and Growth Rate of Molecular Diagnostics in Infectious Disease Testing in Laboratories

      • 4.4.5 Market Size and Growth Rate of Molecular Diagnostics in Infectious Disease Testing in Others

    5 Market Analysis by Regions

    • 5.1 USA Molecular Diagnostics in Infectious Disease Testing Production Analysis by Regions

    • 5.2 USA Molecular Diagnostics in Infectious Disease Testing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis

    • 6.1 West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major Types

    • 6.2 West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major End-Users

    7 South USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis

    • 7.1 South USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major Types

    • 7.2 South USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major End-Users

    8 Middle West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis

    • 8.1 Middle West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major Types

    • 8.2 Middle West USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major End-Users

    9 Northeast USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis

    • 9.1 Northeast USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major Types

    • 9.2 Northeast USA Molecular Diagnostics in Infectious Disease Testing Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Thermo Fisher Scientific

        • 10.1.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 BioTheranostics

        • 10.2.1 BioTheranostics Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Roche

        • 10.3.1 Roche Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 GenMark Diagnostics

        • 10.4.1 GenMark Diagnostics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Siemens

        • 10.5.1 Siemens Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Qiagen

        • 10.6.1 Qiagen Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Luminex

        • 10.7.1 Luminex Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Veridex

        • 10.8.1 Veridex Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 BioMerieux

        • 10.9.1 BioMerieux Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Abbott

        • 10.10.1 Abbott Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Genomix Biotech

        • 10.11.1 Genomix Biotech Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 BD

        • 10.12.1 BD Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Microarrays from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Next-Generation Sequencing (NGS) from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Hybridization from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Academic Institutes from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Laboratories from 2016 to 2027

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Molecular Diagnostics in Infectious Disease Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Molecular Diagnostics in Infectious Disease Testing

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Molecular Diagnostics in Infectious Disease Testing by Different Types from 2016 to 2027

    • Table Consumption Share of Molecular Diagnostics in Infectious Disease Testing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

    • Figure Market Size and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT)

    • Figure Market Size and Growth Rate of Microarrays

    • Figure Market Size and Growth Rate of Next-Generation Sequencing (NGS)

    • Figure Market Size and Growth Rate of Hybridization

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Molecular Diagnostics in Infectious Disease Testing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Molecular Diagnostics in Infectious Disease Testing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Academic Institutes

    • Figure Market Size and Growth Rate of Laboratories

    • Figure Market Size and Growth Rate of Others

    • Table USA Molecular Diagnostics in Infectious Disease Testing Production by Regions

    • Table USA Molecular Diagnostics in Infectious Disease Testing Production Share by Regions

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Production Share by Regions in 2016

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Production Share by Regions in 2021

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Production Share by Regions in 2027

    • Table USA Molecular Diagnostics in Infectious Disease Testing Consumption by Regions

    • Table USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Regions

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Regions in 2016

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Regions in 2021

    • Figure USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Regions in 2027

    • Table West USA Molecular Diagnostics in Infectious Disease Testing Consumption by Types from 2016 to 2027

    • Table West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types from 2016 to 2027

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2016

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2021

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2027

    • Table West USA Molecular Diagnostics in Infectious Disease Testing Consumption by End-Users from 2016 to 2027

    • Table West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2016

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2021

    • Figure West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2027

    • Table South USA Molecular Diagnostics in Infectious Disease Testing Consumption by Types from 2016 to 2027

    • Table South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types from 2016 to 2027

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2016

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2021

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2027

    • Table South USA Molecular Diagnostics in Infectious Disease Testing Consumption by End-Users from 2016 to 2027

    • Table South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2016

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2021

    • Figure South USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2027

    • Table Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption by Types from 2016 to 2027

    • Table Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2016

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2021

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2027

    • Table Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2016

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2021

    • Figure Middle West USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2027

    • Table Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption by Types from 2016 to 2027

    • Table Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2016

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2021

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by Types in 2027

    • Table Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2016

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2021

    • Figure Northeast USA Molecular Diagnostics in Infectious Disease Testing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of BioTheranostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTheranostics

    • Figure Sales and Growth Rate Analysis of BioTheranostics

    • Figure Revenue and Market Share Analysis of BioTheranostics

    • Table Product and Service Introduction of BioTheranostics

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of GenMark Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenMark Diagnostics

    • Figure Sales and Growth Rate Analysis of GenMark Diagnostics

    • Figure Revenue and Market Share Analysis of GenMark Diagnostics

    • Table Product and Service Introduction of GenMark Diagnostics

    • Table Company Profile and Development Status of Siemens

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens

    • Figure Sales and Growth Rate Analysis of Siemens

    • Figure Revenue and Market Share Analysis of Siemens

    • Table Product and Service Introduction of Siemens

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Luminex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luminex

    • Figure Sales and Growth Rate Analysis of Luminex

    • Figure Revenue and Market Share Analysis of Luminex

    • Table Product and Service Introduction of Luminex

    • Table Company Profile and Development Status of Veridex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Veridex

    • Figure Sales and Growth Rate Analysis of Veridex

    • Figure Revenue and Market Share Analysis of Veridex

    • Table Product and Service Introduction of Veridex

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Genomix Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomix Biotech

    • Figure Sales and Growth Rate Analysis of Genomix Biotech

    • Figure Revenue and Market Share Analysis of Genomix Biotech

    • Table Product and Service Introduction of Genomix Biotech

    • Table Company Profile and Development Status of BD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD

    • Figure Sales and Growth Rate Analysis of BD

    • Figure Revenue and Market Share Analysis of BD

    • Table Product and Service Introduction of BD


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.